09/28/2025
After 25 years of research, Brazil has unveiled a medical breakthrough that could change the future of medicine: a drug that may regenerate spinal cord injuries. Developed by Tatiana Coelho de Sampaio and her team at the Federal University of Rio de Janeiro, the treatment — called polylaminin — is derived from placental laminin protein, known for its role in cell growth and repair.
Injected directly into the spine, early trials have shown astonishing outcomes for patients with paraplegia and quadriplegia. Some reported regained movement and improved function, without significant side effects. If validated, this discovery could challenge the long-standing belief that spinal cord damage is permanent.
The drug was developed in partnership with Cristália Laboratory, and while more peer-reviewed studies and regulatory approvals are needed, the potential is immense. Millions of patients worldwide suffering from spinal injuries may finally have hope for recovery. This could be the dawn of a new era in regenerative medicine.
